Recipharm is launching inhalation product solutions following its acquisition of Sanofi’s inhalation manufacturing business and increased use of inhaled drug products.
Opko Health has agreed to acquire Inspiro Medical, an Israeli medical device company developing a new platform to deliver small molecule drugs such as corticosteroids and beta agonists or larger molecules to treat respiratory diseases.
Spanish firm Almirall is working on a new chronic obstructive
pulmonary disease (COPD) treatment combined with a hi-tech easy use
inhaler, creating what it hopes will be another competitive product
from its in-house pipeline.
The growing inhaler device market is driving demand for automated
quality control (QC) testing equipment for these products,
according to Astech Projects.
A new dry powder inhaler that may cost less than a syringe and
deliver 40 per cent more active drug than current inhalers has been
unveiled by its maker, Cambridge Consultants.
The US Food and Drug Administration (FDA) has urged the pharma
industry to develop preservative-free nasal sprays, however, there
is currently a vacuum of manufacturers that can fulfil such a
requirement.
British drug delivery firm Vectura has inked a deal with Boehringer
Ingelheim to develop a dry powder inhaler (DPI) for a range of
proprietary respiratory products of the German company,
intensifying competition in a burgeoning asthma...
The pharmaceutical division of French packaging company Valois has
completed construction of a pilot filling and packaging unit based
at its site in Le Vaudreuil in the Eure area of France, dedicated
to the production of pressurised...
SkyePharma has completed Phase III testing of a new version of
AstraZeneca's asthma drug Pulmicort (budesonide) that does not use
ozone-depleting chlorofluorocarbon (CFC) propellants.
UK drug delivery company SkyePharma expects to make a loss in 2003,
a disappointing result given that it chalked up its first
profitable year just a year earlier, and will cut 10 per cent of
its workforce as a result.
